Gene · 406901
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Cross-Sectional Pilot Analysis of Downregulated Circulating MicroRNAs in Laryngeal Cancer. | Biomedicines | 2025 | 40299445 | PubTator, text mining | PubMed |
| Statement of Retraction: CircSLC7A6 promotes the progression of Wilms' tumor via microRNA-107/ ABL proto-oncogene 2 axis. | Bioengineered | 2025 | 40267145 | PubTator, text mining | PubMed |
| Regulation of KIF23 by miR-107 controls replicative tumor cell fitness in mouse and human hepatocellular carcinoma. | J Hepatol | 2025 | 40235270 | PubTator, text mining | PubMed |
| Artificial intelligence-driven microRNA signature for early detection of gastric cancer: discovery and clinical functional exploration. | Br J Cancer | 2025 | 40234666 | PubTator, text mining | PubMed |
| Laboratory-based Biomarkers for Risk Prediction, Auxiliary Diagnosis and Post-operative Follow-up of Osteoporotic Fractures. | Curr Osteoporos Rep | 2025 | 40199776 | PubTator, text mining | PubMed |
| Translational Insights into Cancer-Associated Fibroblast Infiltration-Related Biomarkers in Glioblastoma and Their Clinical Prognostic Value. | Int J Gen Med | 2025 | 40191237 | PubTator, text mining | PubMed |
| Extracellular vesicles derived microRNAs as non-invasive markers of liver fibrosis in chronically infected HCV patients: a pilot study. | Noncoding RNA Res | 2025 | 40176849 | PubTator, text mining | PubMed |
| miRNA profile in pancreatic neuroendocrine tumors: Preliminary results. | Sci Prog | 2025 | 40152231 | PubTator, text mining | PubMed |
| Alteration of microRNA expression in lymphocytes in patients with first-episode schizophrenia. | BMC Psychiatry | 2025 | 40055650 | PubTator, text mining | PubMed |
| miR-107 suppresses porcine granulosa cell proliferation and estradiol synthesis while promoting apoptosis via targeting PTGS2. | Theriogenology | 2025 | 40024100 | PubTator, text mining | PubMed |
| Exosomal miR-107 Derived From Cigarette Smoking-Exposed Bronchial Epithelial Cells Aggravates Acute Lung Injury by Polarizing Macrophage to Proinflammatory Phenotype. | J Biochem Mol Toxicol | 2025 | 39959948 | PubTator, text mining | PubMed |
| Loss of Tyrosine Phosphatase Mu Promotes Scoliosis Progression Through Osteopontin-α5β1 Integrin Signaling and PIPK1γ90 Activity. | Int J Mol Sci | 2025 | 39940812 | PubTator, text mining | PubMed |
| Tea leaf exosome-like nanoparticles (TELNs) improve oleic acid-induced lipid metabolism by regulating miRNAs in HepG-2 cells. | Bioresour Bioprocess | 2025 | 39930300 | PubTator, text mining | PubMed |
| The role of miRNAs in the associations between particulate matter and ischemic stroke: A nested case-control study. | Environ Pollut | 2025 | 39870131 | PubTator, text mining | PubMed |
| An Anticancer Bioactive Peptide Combined with Oxaliplatin Inhibited Gastric Cancer Cells In vitro and In vivo. | Curr Protein Pept Sci | 2025 | 39791151 | PubTator, text mining | PubMed |
| Exosome-derived miR-107 targeting caveolin-1 promotes gallstone progression by regulating the hepatobiliary cholesterol secretion pathway. | Biochem Pharmacol | 2025 | 39725331 | PubTator, text mining | PubMed |
| Synergic Integration of the miRNome, Machine Learning and Bioinformatics for the Identification of Potential Disease-Modifying Agents in Obstructive Sleep Apnea. | Arch Bronconeumol | 2025 | 39709277 | PubTator, text mining | PubMed |
| H19 promotes polarization and alternative splicing in tumor-associated macrophages, facilitating pancreatic cancer progression. | Cancer Lett | 2025 | 39653238 | PubTator, text mining | PubMed |
| MiR-107 and Its Association With House Dust Mite Sensitisation: Implications for Asthma. | Clin Exp Allergy | 2025 | 39489493 | PubTator, text mining | PubMed |
| MicroRNA-107 - a small RNA with a big impact on cytokinesis in hepatocellular carcinoma. | J Hepatol | 2025 | 39396645 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406901/papers?page=5